Literature DB >> 20494664

Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes.

Nita Chainani-Wu1, Gerdi Weidner, Daniel M Purnell, Steven Frenda, Terri Merritt-Worden, Colleen Kemp, Edward Kersh, Dean Ornish.   

Abstract

Cross-sectional studies have reported inverse associations of B-type natriuretic peptide (BNP) with the body mass index (BMI). We evaluated whether changes in the BMI are associated with changes in BNP. A nested prospective cohort study of a lifestyle intervention (low-fat, whole-foods diet, exercise, stress management, and social support) was conducted. BNP, BMI, and other biomarkers were measured at baseline and 3 months. A total of 131 subjects, 56 with coronary heart disease (CHD) and 75 at high risk, with > or =3 CHD risk factors and/or diabetes mellitus, were enrolled. At 3 months, the mean BMI had decreased (34.4 to 31.7 kg/m(2), p <0.001), BNP had increased (median 18 to 28 pg/ml, p <0.001), and low-density lipoprotein, C-reactive protein, apolipoprotein B (all p <0.002), and angina frequency (p = 0.017) and severity (p = 0.052) had decreased. The subjects' physical limitations had decreased and their physical functioning had improved (all p <0.001). The percentage of change in BNP was inversely associated with the percentage of change in insulin (r = -0.339, p = 0.005, n = 63 nondiabetics). It was also inversely associated with the percentage of change in BMI (r = -0.28, p = 0.002, n = 116), and this association remained significant (p = 0.029) in multiple regression analyses controlling for age, gender, CHD, diabetes mellitus, percentage of change in lifestyle index, and beta-blocker use. The metabolic changes related to adipose tissue lipolysis could explain these findings. In conclusion, BNP increased in subjects experiencing weight loss while following a lifestyle intervention, and angina pectoris, physical limitations, and other CHD risk factors decreased. Therefore, in this context, increasing BNP might not indicate worsening disease or a worsening prognosis. Thus, the proposed use of BNP in monitoring disease progression should take into account changes in the BMI during the same period. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494664     DOI: 10.1016/j.amjcard.2010.01.016

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.

Authors:  Marica Bordicchia; Dianxin Liu; Ez-Zoubir Amri; Gerard Ailhaud; Paolo Dessì-Fulgheri; Chaoying Zhang; Nobuyuki Takahashi; Riccardo Sarzani; Sheila Collins
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

2.  Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.

Authors:  Alain G Bertoni; Lynne E Wagenknecht; Dalane W Kitzman; Santica M Marcovina; Julia T Rushing; Mark A Espeland
Journal:  Obesity (Silver Spring)       Date:  2011-09-29       Impact factor: 5.002

Review 3.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

Review 4.  Brown and beige fat: development, function and therapeutic potential.

Authors:  Matthew Harms; Patrick Seale
Journal:  Nat Med       Date:  2013-09-29       Impact factor: 53.440

Review 5.  Nutritional Interventions in Heart Failure: Challenges and Opportunities.

Authors:  Conor P Kerley
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 6.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

7.  Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels.

Authors:  Annabel Chen-Tournoux; Abigail May Khan; Aaron L Baggish; Victor M Castro; Marc J Semigran; Elizabeth L McCabe; George Moukarbel; Jason Reingold; Sofia Durrani; Gregory D Lewis; Christopher Newton-Cheh; Marielle Scherrer-Crosbie; Lee M Kaplan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2010-11-15       Impact factor: 2.778

Review 8.  Nutrition as Treatment Modality in Heart Failure.

Authors:  Yuta Ishikawa; Elisabeth L P Sattler
Journal:  Curr Atheroscler Rep       Date:  2021-02-17       Impact factor: 5.113

Review 9.  A Review of Plant-based Diets to Prevent and Treat Heart Failure.

Authors:  Conor P Kerley
Journal:  Card Fail Rev       Date:  2018-05

10.  Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies.

Authors:  Roman Pfister; Stephen Sharp; Robert Luben; Paul Welsh; Inês Barroso; Veikko Salomaa; Aline Meirhaeghe; Kay-Tee Khaw; Naveed Sattar; Claudia Langenberg; Nicholas J Wareham
Journal:  PLoS Med       Date:  2011-10-25       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.